SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa and the pending FDA decision on whether to accept it for review are the main focus, with traders debating the odds of priority review and eventual approval. Bulls see regulatory progress and commercial potential, while skeptics point to clinical uncertainty and the funding risks of launching independently without a pharma partner.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMAs Q3 results beat expectations and lifted its earnings outlook, with strong ASCENIV growth and expanding margins dominating discussion. Traders broadly welcomed the post-earnings surge, while some questioned whether the gains can hold given weaker BIVIGAM sales and the need for further quarters to confirm momentum.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms earnings beat has been followed by a sharp selloff, prompting debate over why strong growth has not supported the shares. Traders point to rising delinquencies, credit-loss concerns and higher funding costs, while bulls view the drop as an overreaction and are watching for a rebound.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRGs sharp rebound has renewed debate over its AI/data-center power-demand potential, with some traders pointing to bullish options and dark-pool activity while others question whether expected electricity demand and pricing will hold up. The conversation also reflects concern about the stocks recent volatility and downtrend.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

ETs pullback has traders debating whether higher interest rates, concerns about repeating strong NGL results, and legal overhangs warrant a lower valuation; they are also watching upcoming guidance as a key test. Dip buyers point to the partnerships cash flow, distribution, and potential data-center gas demand, while some say new customer contracts have yet to materialize.

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.

Iambic Therapeutics Inc.

Iambics sharp post-IPO decline is prompting debate over whether the selloff reflects ordinary IPO volatility or deeper concerns, with traders citing ARKs buying and reported insider purchases as bullish counterpoints. Others question the stocks steep retreat and describe it as a failed pump or warn of further selling.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,642,432,860.16906072. The last known price of Dogecoin is 0.07236495 USD and is up 0.12 over the last 24 hours. It is currently trading on 1544 active market(s) with $471,787,083.15 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a prolonged, choppy decline alongside broader crypto weakness, with traders focused on technical support and resistance. Bearish commenters warn of further losses and question DOGEs staying power, while holders treat dips as buying opportunities and look for a rebound; no single DOGE-specific catalyst dominates.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,067.29. The last known price of BNB is 693.11665658 USD and is down -0.20 over the last 24 hours. It is currently trading on 3525 active market(s) with $1,380,798,663.86 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

A reported record-scale Binance security breach and withdrawal disruption dominate discussion around BNB. Traders worry about customer-fund safety, outflows, and spillover to crypto, while others argue Binance can cover losses and see the selloff as a buying opportunity.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

Healthcares defensive-sector strength and rotation away from technology and semiconductors are driving attention to XLV, with traders pointing to its rally and broad sector momentum. Sentiment is mostly bullish, though some see profit-taking or a pullback risk, and options activity reflects uncertainty about the next move.

Select Sector SPDR Trust (The) - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

A rotation from technology into defensive consumer staples has driven a sharp run in XLP, with traders also discussing its pullback and possible reversal. Some see the defensive bid as a sign of risk aversion, while others argue the move is extended and may be fading as money rotates back toward growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agilysys: 3 Key Takeaways for Long-Term Investors

Key PointsSubscription revenue grew 32.6% year over year to $44.2 million...

All You Need to Know About Agilysys (AGYS) Rating Upgrade to Buy

Agilysys (AGYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Why Agilysys (AGYS) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Agilysys (AGYS) Q2 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Agilysys (AGYS) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Agilysys (AGYS) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Agilysys (AGYS) Q2 Earnings and Revenues Surpass Estimates

Agilysys (AGYS) delivered earnings and revenue surprises of +21.82% and +2.21%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Agilysys Announces Record Revenue of $93.4M in Fiscal 2027 Second Quarter

Agilysys, Inc. (NASDAQ: AGYS), a leading global provider of hospitality software solutions and services, today reported results for its fiscal 2027 second quarter ending September 30, 2026. Summary of Fiscal 2027 Second Quarter Financial Results Total net revenue increased 17.7% to a record $93.4...

HPE vs. AGYS: Which Stock Is the Better Value Option?

Seagate Eyes a Q1 Earnings Beat: Is the Stock Worth Buying Now?

STX's Q1 FY27 earnings outlook reflects surging AI-driven storage demand, higher pricing and Mozaic technology growth. 

Gear Up for Agilysys (AGYS) Q2 Earnings: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agilysys (AGYS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.

Agilysys, Inc. operates as a technology company. It offers innovative software for point-of-sale, payment gateway, reservation and table management, guest offers management, property management, inventory and procurement, analytics, document management, and mobile and wireless solutions and services to the hospitality industry. The firm also serves the gaming industry for both corporate and tribal, hotels resort and cruise, foodservice management, and the restaurant, university, and healthcare sectors. The company was founded in 1963 and is headquartered in Alpharetta, GA.

Agilysys, Inc

AGYS Stock Soars On Robust Guidance, Q4 Earnings Beat

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>AGYS posted adjusted earnings per share of $0.63 for the fourth quarter ended March 31, beating the analyst estimate of $0.50.&nbsp;</li><li>Revenue rose 11.7% YoY to a record $82.9 million.</li><li>Five out of six analysts rate the stock ‘buy’ and one rates ‘sell.’</li></ul>Agilysys, Inc (<a href="https://stocktwits.com/symbol/AGYS">AGYS</a>) share price surged 16% after-hours after the company reported better-than-expected results for the fourth quarter and issued fiscal 2027 guidance above estimates.&nbsp;&nbsp;The hospitality software provider posted adjusted earnings of $0.63 per share for the fourth quarter ended March 31, beating the analyst estimate of $0.50. Revenue rose 11.7% year-on-year (YoY) to a record $82.9 million, rising past estimates of $81.56 million, as per&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://fical.ai">Fiscal.ai</a> data.&nbsp;&nbsp;"We are pleased to announce a 17th consecutive record revenue quarter of $82.9 million, including 24.1% subscription revenue growth," said Ramesh Srinivasan, President and CEO. "Fiscal 2026 was an outstanding year across all crucial major metrics, including record shattering sales and world class customer retention levels, which has positioned us well for another record year in Fiscal 2027."&nbsp;For the full fiscal year 2026, AGYS reported record revenues of $319.3 million, up 15.9% YoY, and ahead of estimates of $317.9 million. Adjusted EPS for the year was $1.79, compared to $1.55 in fiscal 2025 and expectations of $1.65 for the year.&nbsp;<h2 class="st-heading-2">AGYS Fiscal 2027 Outlook&nbsp;</h2>The company expects fiscal year 2027 revenue to be $365 million to $370 million, well above analyst expectations of $363.59 million. The firm expects at least 30% year-over-year subscription revenue growth.&nbsp;“The sales momentum throughout the fiscal year has carried us into Fiscal 2027 well-positioned to achieve another year of record revenue and profitability levels,” said Dave Wood, Chief Financial Officer, Agilysys.&nbsp;<h2 class="st-heading-2">AGYS Retail View&nbsp;</h2>Retail sentiment on Stocktwits was ‘extremely bullish’ with ‘extremely high’ message volumes.&nbsp;One user highlighted there was a “lot to like” about the stock’s movement.&nbsp;<stembedurl>https://stocktwits.com/topstockalerts/message/653750270</stembedurl>The stock has lost 18.4% over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lunr-stock-jumps-on-winning-nasa-lunar-imaging-contracts-worth-20-m/cZXrzTDRemu">LUNR Stock Jumps On Winning NASA Lunar Imaging Contracts Worth $20M</a> &nbsp; &nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Agilysys, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on January 2, 2025. 

Agilysys, Inc (AGYS) share price surged 16% after-hours after the company reported better-than-expected results for the fourth quarter and issued fiscal 2027 guidance above estimates.&nbsp;&nbsp;

Agilysys reports record quarterly (Q4) and annual revenue.

Abacus FCF Small Cap Leaders ETF

WisdomTree Cloud Computing Fund

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.59	--	--	N/A
Q2 '26	$0.55	$0.67	21.54%	BEAT
Q1 '26	$0.40	$0.49	21.74%	BEAT
Q4 '25	$0.50	$0.63	26.72%	BEAT
Q3 '25	$0.46	$0.42	-7.84%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

AGYS Earnings

Latest Earnings Results: Q2 '26

Historical Earnings